On the other hand, the data presented here suggest that targeting ATF6α may be beneficial in selective contexts of inflammation that evoke an IL-12/IL-6 cytokine response, which may include infection with intracellular bacteria or certain autoimmune contexts (Gee et al., 2009). The gene discussed is ATF6; the disease is infection.